Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 2
1992 1
1993 3
1994 6
1995 4
1996 4
1997 6
1998 8
1999 11
2000 8
2001 4
2002 9
2003 5
2004 6
2005 3
2006 4
2007 7
2008 3
2009 6
2010 9
2011 16
2012 8
2013 8
2014 7
2015 5
2016 4
2017 9
2018 7
2019 7
2020 4
2021 4
2022 8
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.
Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS. Ang KK, et al. Among authors: bonner ja. J Clin Oncol. 2014 Sep 20;32(27):2940-50. doi: 10.1200/JCO.2013.53.5633. J Clin Oncol. 2014. PMID: 25154822 Free PMC article. Clinical Trial.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
HiJAKing Immunotherapy-Resistant Melanoma for a Cure.
Shi LZ, Shen H, Ojo OA, Bonner JA. Shi LZ, et al. Among authors: bonner ja. Oncologist. 2023 Mar 17;28(3):196-198. doi: 10.1093/oncolo/oyac270. Oncologist. 2023. PMID: 36640142 Free PMC article.
p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA, Mesia R, Giralt J, Psyrri A, Keilholz U, Rosenthal DI, Beier F, Schulten J, Vermorken JB. Bonner JA, et al. Oncologist. 2017 Jul;22(7):811-822. doi: 10.1634/theoncologist.2016-0433. Epub 2017 May 18. Oncologist. 2017. PMID: 28526718 Free PMC article. Review.
Management of extramedullary plasmacytomas.
Bonner JA, Dragovic J, Abrash MP. Bonner JA, et al. Henry Ford Hosp Med J. 1987;35(4):245-50. Henry Ford Hosp Med J. 1987. PMID: 3329173 Free article. Review. No abstract available.
EGFR Mutations in Head and Neck Squamous Cell Carcinoma.
Nair S, Bonner JA, Bredel M. Nair S, et al. Among authors: bonner ja. Int J Mol Sci. 2022 Mar 30;23(7):3818. doi: 10.3390/ijms23073818. Int J Mol Sci. 2022. PMID: 35409179 Free PMC article. Review.
In Regard to Bossi et al.
Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT. Fakhry C, et al. Among authors: bonner ja. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. Int J Radiat Oncol Biol Phys. 2018. PMID: 30238902 No abstract available.
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Gharzai LA, Morris E, Suresh K, Nguyen-Tân PF, Rosenthal DI, Gillison ML, Harari PM, Garden AS, Koyfman S, Caudell JJ, Jones CU, Mitchell DL, Krempl G, Ridge JA, Gensheimer MF, Bonner JA, Filion E, Dunlap NE, Stokes WA, Le QT, Torres-Saavedra P, Mierzwa M, Schipper MJ. Gharzai LA, et al. Among authors: bonner ja. Lancet Oncol. 2024 Mar;25(3):366-375. doi: 10.1016/S1470-2045(24)00016-0. Lancet Oncol. 2024. PMID: 38423050
186 results